Robbins JB - Search Results

1

Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.

Mai NL, Phan VB, Vo AH, Tran CT, Lin FY, Bryla DA, Chu C, Schiloach J, Robbins JB, Schneerson R, Szu SC. Mai NL, et al. Among authors: robbins jb. N Engl J Med. 2003 Oct 2;349(14):1390-1. doi: 10.1056/NEJM200310023491423. N Engl J Med. 2003. PMID: 14523155 No abstract available.

2

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, Kossaczka Z, Bryla DA, Shiloach J, Robbins JB, Schneerson R, Szu SC. Lin FY, et al. Among authors: robbins jb. N Engl J Med. 2001 Apr 26;344(17):1263-9. doi: 10.1056/NEJM200104263441701. N Engl J Med. 2001. PMID: 11320385 Free article. Clinical Trial.

3

Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children.

Canh DG, Lin FY, Thiem VD, Trach DD, Trong ND, Mao ND, Hunt S, Schneerson R, Robbins JB, Chu C, Shiloach J, Bryla DA, Bonnet MC, Schulz D, Szu SC. Canh DG, et al. Among authors: robbins jb. Infect Immun. 2004 Nov;72(11):6586-8. doi: 10.1128/IAI.72.11.6586-6588.2004. Infect Immun. 2004. PMID: 15501790 Free PMC article. Clinical Trial.

4

Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D.

Robbins JB, Schneerson R. Robbins JB, et al. N Engl J Med. 1990 Nov 15;323(20):1415-6. doi: 10.1056/NEJM199011153232010. N Engl J Med. 1990. PMID: 2233910 No abstract available.

5

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R. Shinefield H, et al. Among authors: robbins jb. N Engl J Med. 2002 Feb 14;346(7):491-6. doi: 10.1056/NEJMoa011297. N Engl J Med. 2002. PMID: 11844850 Free article. Clinical Trial.

6

Future vaccine development at NICHD.

Robbins JB, Schneerson R. Robbins JB, et al. Ann N Y Acad Sci. 2004 Dec;1038:49-59. doi: 10.1196/annals.1315.011. Ann N Y Acad Sci. 2004. PMID: 15838097

7

The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.

Thiem VD, Lin FY, Canh DG, Son NH, Anh DD, Mao ND, Chu C, Hunt SW, Robbins JB, Schneerson R, Szu SC. Thiem VD, et al. Among authors: robbins jb. Clin Vaccine Immunol. 2011 May;18(5):730-5. doi: 10.1128/CVI.00532-10. Epub 2011 Mar 16. Clin Vaccine Immunol. 2011. PMID: 21411598 Free PMC article.

8

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.

Szu SC, Stone AL, Robbins JD, Schneerson R, Robbins JB. Szu SC, et al. Among authors: robbins jb, robbins jd. J Exp Med. 1987 Nov 1;166(5):1510-24. doi: 10.1084/jem.166.5.1510. J Exp Med. 1987. PMID: 3681191 Free PMC article.

9

Standardization may suffice for licensure of conjugate vaccines.

Robbins JB, Schneerson R, Szu SC, Bryla DA, Lin FY, Gotschlich EC. Robbins JB, et al. Dev Biol Stand. 1998;95:161-7. Dev Biol Stand. 1998. PMID: 9855427 Review.

10

Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas A, Hunt S, Bryla DA, Schneerson R, Robbins JB, Szu SC. Kossaczka Z, et al. Among authors: robbins jb. Infect Immun. 1999 Nov;67(11):5806-10. doi: 10.1128/IAI.67.11.5806-5810.1999. Infect Immun. 1999. PMID: 10531232 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters